Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine vs Povidine-Iodine for Intravitreal Injection Antisepsis
NCT03571100Phase 1Unknown
- Sponsor
- Mid Atlantic Retina
- Start
- May 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of chlorhexidine in age-related macular degeneration (AMD), diabetic macular edema (DME), retinopathy and 1 more (2 arms), sponsored by Mid Atlantic Retina. Primary endpoint: Patient Comfort at 1 day. Status: unknown.
02
Drugs
chlorhexidine
03
Conditions
age-related macular degeneration (AMD)diabetic macular edema (DME)retinopathyretinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT03571100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03571100.